Originally published January 8, 2009 at 12:00 AM | Page modified January 8, 2009 at 12:05 AM
FDA rates drug made from goat milk safe, effective
In what would be a scientific first, an anti-clotting drug made from the milk of genetically engineered goats moved closer to government approval Wednesday after experts at the Food and Drug Administration (FDA) reported that the medication works and its safety is acceptable.
The Associated Press
WASHINGTON — In what would be a scientific first, an anti-clotting drug made from the milk of genetically engineered goats moved closer to government approval Wednesday after experts at the Food and Drug Administration (FDA) reported that the medication works and its safety is acceptable.
Called ATryn, the drug is intended to help people with a rare hereditary disorder that makes them vulnerable to life-threatening blood clots.
Its approval would be a major step toward new kinds of medications made not from chemicals but from living organisms genetically manipulated by scientists.
ATryn was developed by a Massachusetts biotechnology company, GTC Biotherapeutics, by altering the genes of goats so they would produce milk rich in antithrombin, a protein that in humans acts as a natural blood thinner.
About one in every 5,000 people don't produce enough of the protein, putting them at risk of developing blood clots in their veins.
Such clots can be extremely painful. If they break loose and travel through the bloodstream to the lungs or the brain, the consequences can be catastrophic. Pregnant women with the disorder are at high risk of miscarriage or stillbirth, because of blood clots in the placenta.
In their everyday lives, patients with antithrombin deficiency are managed with conventional blood thinners. That would not change. ATryn is for use only when patients are having surgery or having a baby, times when the risk of dangerous clots is particularly high.
"It's the first time we've held an advisory committee meeting on any product from a genetically engineered animal," FDA spokeswoman Siobhan DeLancey said.
If the drug is approved, the FDA may require follow-up monitoring to make sure that patients' immune systems don't start making antibodies in reaction to the medication.
Copyright © 2009 The Seattle Times Company
UPDATE - 10:01 AM
Rebels tighten hold on Libya oil port
UPDATE - 09:29 AM
Reality leads US to temper its tough talk on Libya
UPDATE - 09:38 AM
2 Ark. injection wells may be closed amid quakes
Armed guards save Dutch couple from Somali pirates
Navy to release lewd video investigation findings

- Lakewood cop accused of embezzling $150K meant for slain officers' families
- 3 big health insurers stockpile $2.4 billion as rates keep rising
- Agency set to investigate handling of 911 call about Josh Powell
- Quick decisions: How Washington hired its new football staff
- Historic day for gay marriage as another fight looms
- Justin Wilcox's versatile defensive style is the right fit for Huskies | Jerry Brewer
- Social worker recounts minutes before Powell fire
- It's Terrence Time: Enigmatic Ross leads Huskies
- $25B settlement reached over foreclosure abuses
- Club promoter convicted in brutal 2010 murder of Des Moines prostitute
- Gay-marriage bill passes House, awaits Gregoire's signature
471 - Historic day for gay marriage as another fight looming
359 - Wanted in Seattle classrooms: more teachers of color
291 - 3 big health insurers stockpile $2.4 billion as rates keep rising
243 - Source: NY, California to sign mortgage settlement
231 - Oregon live game thread
155 - Council members get briefing on arena proposal, minus details
143 - Pac-12 picks ... including the UW game
140 - AP Source: Obama to change birth control rule
129 - Worker: Josh Powell told son he had 'surprise'
101
- State Medicaid program to stop paying for unneeded ER visits
- 3 big health insurers stockpile $2.4 billion as rates keep rising
- Wanted in Seattle classrooms: more teachers of color
- One man's audacious pursuit of sailing history
- Darren Berg gets 18-year sentence for Ponzi scheme
- $25B settlement reached over foreclosure abuses
- Economy, blogs give survivalists new reason to look to Northwest
- State's share of mortgage settlement: $648 million
- Bellevue College adds a third bachelor's degree program
- 'Gauguin and Polynesia': dazzling mix-and-match | Art review
